Past and future of prophylactic ablation of the cervical squamocolumnar junction

about

Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.Comprehensive Human Papillomavirus Genotyping in Cervical Squamous Cell Carcinomas and Its Relevance to Cervical Cancer Prevention in Malawian Women

P2860

Q33613540-9361F3D9-1A41-41EC-A2AB-C036EEF085C0 Q33859491-687841F0-64E6-4920-B06C-1C6E704AC152

P2860

Past and future of prophylactic ablation of the cervical squamocolumnar junction

Item

http://www.wikidata.org/entity/Q35605616

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@ast

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@en

type

Item

label

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@ast

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@en

prefLabel

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@ast

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@en

P1476

Past and future of prophylactic ablation of the cervical squamocolumnar junction

@en

P2860

Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis

WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention

Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies.

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trials

Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.

Histologic development of cervical ectopy: relationship to reproductive hormones.

Estrogen and ERalpha: culprits in cervical cancer?

Lower cost strategies for triage of human papillomavirus DNA-positive women.

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

P304

527

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3332/ECANCER.2015.527

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Silvia Franceschi

P577

2015-04-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276123456

http://www.w3.org/2001/XMLSchema#string

P698

25987896

http://www.w3.org/2001/XMLSchema#string

P932

4431400

http://www.w3.org/2001/XMLSchema#string

Past and future of prophylactic ablation of the cervical squamocolumnar junction

about

P2860

P2860

Past and future of prophylactic ablation of the cervical squamocolumnar junction

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932